Hippocratic AI Secures $141M in Series B Funding, Reaching $1.64B Valuation
Healthcare-focused AI startup Hippocratic AI has successfully closed its Series B financing round, raising $141 million, led by Kleiner Perkins. This funding boost brings the company’s valuation to $1.64 billion, marking a significant milestone just nine months after its Series A round.
Key Highlights of the Series B Round:
- Lead Investor: Kleiner Perkins
- Existing Investors: General Catalyst, Premji Invest, Andreessen Horowitz (A16z), NVIDIA, SV Angel, Universal Health Services (UHS), WellSpan Health, among others.
- Funding Total to Date: $278 million
Expansion Plans and Objectives:
Hippocratic AI plans to use the funds to accelerate global healthcare improvements, focusing on patient outcomes through its Polaris Large Language Model (LLM). Key initiatives include:
- Expanding into new verticals like pharmaceuticals and payors.
- Extending its global footprint across Europe, the Middle East, Africa (EMEA), Southeast Asia, and Latin America.
Technology and Innovations:
- Polaris 2.0: The company’s next-gen safety-focused healthcare conversation system with 3.7 trillion parameters, designed for greater intelligence and clinical safety than its predecessor, Polaris 1.0. It supports 14 languages, broadening its accessibility.
- AI Agent App Store: A new platform that enables licensed clinicians to collaborate in designing AI agents tailored to specific healthcare use cases, boosting customization and precision in patient care.
Founding Team:
- Co-founder and CEO: Munjal Shah
- The team includes professionals from El Camino Health, Johns Hopkins, Stanford, Microsoft, Google, and NVIDIA, blending healthcare expertise with cutting-edge AI research.
CEO’s Vision:
Munjal Shah expressed that the funding will help accelerate the development and deployment of Hippocratic GenAI-driven super staffing, moving the company closer to its goal of making healthcare abundance a reality.
Outlook:
With a growing focus on AI-driven healthcare solutions, Hippocratic AI is positioning itself to be a key player in global health transformation. Its commitment to safety-driven AI models and the development of tools that support clinicians directly could see it gaining traction across healthcare systems worldwide.
